Henry Waxman spent four decades in Congress relentlessly going after drug companies for what he charged was their profit-padding.
The California Democrat left Capitol Hill in 2015, but he hasn’t given up battling big pharma.
Waxman is now working as a lobbyist for hospitals and medical clinics to protect a drug discount program, known as 340B, that he helped create 24 years ago. He is urging federal regulators to resist calls by the drug industry’s leading trade group to put new restrictions on the program, which was designed to help hospitals better treat poor patients by requiring drug makers to offer medicines at a steep discount.
